A viral vector expressing hypoxia-inducible factor 1 alpha inhibits hippocampal neuronal apoptosis

Neural Regeneration Research

Volumn 9, Issue 11, 2014, Pages 1145-1153

  Chai, Xi Qing ^a   Kong, Wei Na ^a   Liu, Ling Yun ^b   Yu, Wen Guo ^a   Zhang, Zhen Qing ^c   Sun, Yi Min ^a  

^a HEBEI UNIVERSITY   (China)

^b Tongji University School of Medicine   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Adeno associated virus; Alzheimer's disease; Apoptosis; Calcium concentration; Gene therapy; Hypoxia inducible factor 1 ; Intracerebroventricular injection; Nerve regeneration; Neural regeneration; NSFC grant; Transduction

Indexed keywords

AMYLOID BETA PROTEIN [25-35]; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; EXPRESSION VECTOR; FLOW CYTOMETRY; HIPPOCAMPUS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 84904265385     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.135317     Document Type: Article

References (41)

1. Avramovich-Tirosh Y, Bar-Am O, Amit T, Youdim M, Weinreb O (2010) Up-regulation of hypoxia-inducible factor (HIF)-1 and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30. Curr Alzheimer Res 7: 300-306.
2. Banker GA, Cowan WM (1977) Rat hippocampal neurons in dispersed cell culture. Brain Res 126:397-425.
3. Bartlett JS, Kleinschmidt J, Boucher RC, Samulski RJ (1999) Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody. Nat Biotechnol 17: 181-186.
4. Beneduci A, Chidichimo G, Tripepi S, Perrotta E (2005) Transmission electron microscopy study of the effects produced by wide-band low-power millimeter waves on MCF-7 human breast cancer cells in culture. Anticancer Res 25:1009-1013.
5. Braddock M (2005) Safely slowing down the decline in Alzheimer's disease: gene therapy shows potential. Expert Opin Investig Drugs 14: 913-915.
6. Carty NC, Nash K, Lee D, Mercer M, Gottschall PE, Meyers C, Muzyczka N, Gordon MN, Morgan D (2008) Adeno-associated viral (AAV) serotype 5 vector mediated gene delivery of endothelin-converting enzyme reduces Abeta deposits in APP + PS1 transgenic mice. Mol Ther 16:1580-1586.
7. Dotti CG, Sullivan CA, Banker GA (1988) The establishment of polarity by hippocampal neurons in culture. J Neurosci 8:1454-1468. Fernández-
8. Fernández-Morales JC, Arranz-Tagarro JA, Calvo-Gallardo E, Maroto M, Padín JF, García AG (2012) Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimer's disease. ACS Chem Neurosci 3:873-883.
9. Greijer A, Van der Wall E (2004) The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 57:1009-1014.
10. Hong CS, Goins WF, Goss JR, Burton EA, Glorioso JC (2006) Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-β peptide in vivo. Gene Ther 13:1068-1079.
11. Kong WN, Zhao SE, Duan XL, Yang Z, Qian ZM, Chang YZ (2008) Decreased DMT1 and increased ferroportin 1 expression is the mechanisms of reduced iron retention in macrophages by erythropoietin in rats. J Cell Biochem 104:629-641.
12. Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582:359-364.
13. Manukhina E, Goryacheva A, Barskov I, Viktorov I, Guseva A, Pshennikova M, Khomenko I, Mashina SY, Pokidyshev D, Malyshev IY (2010) Prevention of neurodegenerative damage to the brain in rats in experimental Alzheimer's disease by adaptation to hypoxia. Neurosci Behav Physiol 40:737-743.
14. Marchesi VT (2011) Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 25:5-13.
15. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 376-389.
16. Maxwell PH (2005) Hypoxia-inducible factor as a physiological regulator. Exp Physiol 90:791-797.
17. Murray IV, Proza JF, Sohrabji F, Lawler JM (2011) Vascular and metabolic dysfunction in Alzheimer's disease: a review. Exp Biol Med (Maywood) 236:772-782.
18. Musiani M, Zerbini M, Gibellini D, Gentilomi G, La Placa M, Ferri E, Girotti S (1991) Chemiluminescent assay for the detection of viral and plasmid DNA using digoxigenin-labeled probes. Anal Biochem 194:394-398.
19. Nordal RA, Nagy A, Pintilie M, Wong CS (2004) Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury a role for vascular endothelial growth factor. Clin Cancer Res 10:3342-3353.
20. Palop JJ, Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66:435-440.
21. Pike CJ, Cummings BJ, Cotman CW (1992) [beta]-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. Neuroreport 3:769-772.
22. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW (1995) Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64:253-265.
23. Piret JP, Minet E, Cosse JP, Ninane N, Debacq C, Raes M, Michiels C (2005) Hypoxia-inducible factor-1-dependent overexpression of myeloid cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide-induced apoptosis. J Biol Chem 280:9336-9344.
24. Pluta K, Luce MJ, Bao L, Agha-Mohammadi S, Reiser J (2005) Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J Gene Med 7: 803-817.
25. Sasabe E, Tatemoto Y, Li D, Yamamoto T, Osaki T (2005) Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci 96:394-402.
26. Schubert D, Soucek T, Blouw B (2009) The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci 29:1323-1334.
27. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron 39:43-56.
28. Stepanichev MY, Zdobnova IM, Yakovlev AA, Onufriev MV, Lazareva NA, Zarubenko II, Gulyaeva NV (2003) Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25-35). J Neurosci Res 71:110-120.
29. Stepanichev MY, Zdobnova IM, Zarubenko II, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV (2004) Amyloid-beta (25-35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav 80:647-655.
30. Stepanichev MY, Zdobnova IM, Zarubenko II, Lazareva NA, Gulyaeva NV (2006) Studies of the effects of central administration of β-amyloid peptide (25-35): pathomorphological changes in the hippocampus and impairment of spatial memory. Neurosci Behav Physiol 36: 101-106.
31. Stepanov II, Kuznetsova NN, Klement'ev BI, Sapronov NS (2007) Effects of intracerebroventricular administration of beta-amyloid on the dynamics of learning in purebred and mongrel rats. Neurosci Behav Physiol 37:583-590.
32. Tuszynski MH (2007) Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 21:179-189.
33. Wray S, Baisden RH, Woodruff ML (1991) Neurochemical anatomy of fetal hippocampus transplanted into large lesion cavities made in the adult rat brain. Exp Neurol 111:36-48.
34. Wu Z, Wu X, Cao H, Dong X, Wang H, Hou Y (2002) A novel and highly efficient production system for recombinant adeno-associated virus vector. Sci China C Life Sci 45:96-104.
35. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, Matsuno T, Kawashima S, Nabeshima T (2006) Effects of a Novel Cognitive Enhancer, Spiro [imidazo-[1, 2-a] pyridine-3, 2-indan]-2 (3H)-one (ZSET1446), on Learning Impairments Induced by Amyloid-β1-40 in the Rat. J Pharmacol Exp Ther 317:1079-1087.
36. Zhang J, Wu X, Qin C, Qi J, Ma S, Zhang H, Kong Q, Chen D, Ba D, He W (2003) A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and β-amyloid plaques in a mouse model of Alzheimer's disease. Neurobiol Dis 14:365-379.
37. Zhang J, Yu Z, Yu Z, Yang Z, Zhao H, Liu L, Zhao J (2011) rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model. Int J Clin Exp Pathol 4:496.
38. Zhang J, Zhen YF, Song LG, Kong WN, Shao TM, Li X, Chai XQ (2013) Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus. Behav Brain Res 244:70-81.
39. Zhao L, Wu J, Zhang X, Kuang H, Guo Y, Ma L (2013) The effect of Shenmai injection on the proliferation of Rat airway smooth muscle cells in asthma and underlying mechanism. BMC Complement Altern Med 13:221.
40. Zhou LJ, Zhu XZ (2000) Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. J Pharmacol Exp Ther 293:982-988.
41. Zussy C, Brureau A, Delair B, Marchal S, Keller E, Ixart G, Naert G, Meunier J, Chevallier N, Maurice T, Givalois L (2011) Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats. Am J Pathol 179:315-334.